Review Article

Published: Sep 10, 2026 | DOI: 10.24911/JBCGenetics.11-2935

Role of CLIP technologies in understanding RNA–protein interactions in neurological and neuro-oncological disorders: a narrative review


Authors: Ahmed Mohammed Almutairi , Abdulrahman Saleh Alshakrh , Khaliel Rafee Almutairi , Abdullah Ayad Alaujan , Amal Mohammed Almutiry


Abstract

RNA-binding proteins are essential regulators of post-transcriptional gene expression, controlling RNA splicing, transport, localization, stability, and translation within the nervous system. Dysregulation of RNA–protein interaction networks has emerged as a critical mechanism underlying multiple neurogenetic and neurodegenerative disorders. Crosslinking and Immunoprecipitation technologies, including High-Throughput Sequencing Crosslinking and Immunoprecipitation, Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation, Individual-Nucleotide Resolution Crosslinking and Immunoprecipitation, and Enhanced Crosslinking and Immunoprecipitation, have significantly advanced the ability to identify transcriptome-wide RNA-binding protein interaction sites with high specificity and resolution. These methodologies have enabled detailed characterization of RNA regulatory networks involved in neuronal homeostasis, synaptic plasticity, neurodegeneration, and tumor progression. This narrative review summarizes the principles and major variants of Crosslinking and Immunoprecipitation technologies and discusses their applications in neurogenetic disorders, including amyotrophic lateral sclerosis, Fragile X syndrome, Alzheimer’s disease, and neuroblastoma. Furthermore, the review highlights current technical limitations, analytical challenges, and future perspectives involving single-cell transcriptomics, multi-omics integration, artificial intelligence, and RNA-targeted therapeutic development. Collectively, Crosslinking and Immunoprecipitation-based methodologies represent powerful tools for elucidating disease-associated RNA regulatory mechanisms and may contribute to the identification of novel biomarkers and therapeutic targets in neurological and neuro-oncological diseases.


Keywords: CLIP, RNA-binding proteins, RNA–protein interactions, neurological disorders, neurodegenerative diseases, neuro-oncology, HITS-CLIP, PAR-CLIP, iCLIP, eCLIP, irCLIP, uvCLAP.



Pubmed Style

Ahmed Mohammed Almutairi, Abdulrahman Saleh Alshakrh, Khaliel Rafee Almutairi, Abdullah Ayad Alaujan, Amal Mohammed Almutiry. Role of CLIP technologies in understanding RNA–protein interactions in neurological and neuro-oncological disorders: a narrative review. JBC Genetics. 2026; 10 (September 2026): -. doi:10.24911/JBCGenetics.11-2935

Publication History

Received: August 13, 2025

Revised: July 13, 2026

Accepted: July 19, 2026

Published: September 10, 2026


Authors

Ahmed Mohammed Almutairi

Department of Medical Laboratories, Total Laboratory Automation (TLA) Laboratory, King Saud University, King Khalid University Hospital.

Abdulrahman Saleh Alshakrh

Department of Medical Laboratories, Total Laboratory Automation (TLA) Laboratory, King Saud University, King Khalid University Hospital.

Khaliel Rafee Almutairi

Department of Medical Laboratories, Total Laboratory Automation (TLA) Laboratory, King Saud University, King Khalid University Hospital.

Abdullah Ayad Alaujan

Department of Medical Laboratories, Total Laboratory Automation (TLA) Laboratory, King Saud University, King Khalid University Hospital.

Amal Mohammed Almutiry

Regional Dental Center, Ministry of Health, Qassim, Saudi Arabia.